Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9603 posts found.

Cervarix US approval delayed

December 19, 2007 Research and Development, Sales and Marketing

GlaxoSmithKline's cervical cancer vaccine Cervarix has suffered a setback in the US, where regulators have refused to approve it until …
News

Latest news from Datamonitor

December 18, 2007 Research and Development

BioMS's multiple sclerosis trial receives positive review from DSMBThe Data Safety Monitoring Board has reviewed data from BioMS Medical's ongoing …
News

Eisai signs $3.9bn biotech deal

December 14, 2007 Research and Development, Sales and Marketing Eisai

Japanese pharma company Eisai has acquired Minnesota-based biotech MGI Pharma for $3.9 billion, significantly boosting its oncology business.It is Eisai’s …
News

GSK boosts portfolio in cancer and anti-infectives

December 14, 2007 Research and Development

GSK has secured two new early-stage biotech licensing deals to boost its product pipeline.The UK-based group unveiled one partnership with …
News

Get ready for inspection

December 13, 2007 Research and Development MHRA, inspection, reg affairs

No one looks forward to receiving a letter from the MHRA (Medicines and Healthcare products Regulatory Agency) inspectorate announcing their …
Feature

Latest news from Datamonitor

December 10, 2007 Research and Development

Adventrx completes enrolment for breast cancer trialAdventrx Pharmaceuticals has completed patient enrolment in its Phase II clinical trial of CoFactor …
News

Safety first

December 10, 2007 Research and Development, Sales and Marketing clinical trials, drug development, drug safety

There is a tide of change in drug safety within the pharmaceutical industry.  Internal and external forces are pushing drug …
Feature

Sanofi and Regeneron sign antibody deal

November 30, 2007 Research and Development

Sanofi-Aventis has increased its stake in Regeneron and will collaborate with the US biotech company on new antibody research.The companies …
News

Latest news from Datamonitor

November 29, 2007 Research and Development

Medivir to initiate Phase IIa study of hepatitis CMedivir has announced that a Phase IIa study for its investigational hepatitis …
News

Pfizer buys immune system specialists Coley

November 22, 2007 Research and Development

Pfizer is to acquire a company developing new drugs that fight diseases by altering the immune system. The company is …
News

GSK pays $1.65 billion for cardiovascular specialists Reliant

November 22, 2007 Research and Development

News

Latest news from Datamonitor

November 20, 2007 Research and Development

Aeterna completes enrollment for Phase II trial of lung cancerAeterna Zentaris has completed patient recruitment for its European multi-center Phase …
News

A meeting of minds: working with academia

November 9, 2007 Research and Development, Sales and Marketing academia, partnerships, pharma

Feature

CROs included in clinical trials fast track

November 2, 2007 Research and Development

Efforts to cut unnecessary delays to UK clinical trials have taken a step forward with a new agreement to help …
News

Redefining pharmaceutical CRM

October 24, 2007 Research and Development, Sales and Marketing CRM, customer relationship management, sales

Fierce generic competition, price containment regulations and poor pipeline productivity are challenges looming over many pharmaceutical companies today. In effect, …
Feature
The Gateway to Local Adoption Series

Latest content

Thermo Fisher opens new distribution centre in Ireland

March 12, 2026

Altimetrik appoints Dhirendra Nath as Chief Human Resources Officer

March 12, 2026

Kindeva appoints Mike Cowhig as Chief Legal Officer

March 11, 2026

DiaMedica gets regulatory clearance from Health Canada for phase 2 preeclampsia study

March 11, 2026

Abselion establishes a US subsidiary in Massachusetts 

March 10, 2026